Sponsor exit routes: sale, IPO, and the dual-track process

Every deal starts with the end in mind

A sponsor doesn't buy a company to hold it forever. Every acquisition is underwritten with an eventual exit assumption baked into the return math, covered in LBO returns: IRR, MOIC, and the three levers of value creation, and a sponsor's fee-and-carry economics, covered in how private equity firms make money, only actually pay off once an investment is realized, not while it's simply sitting in the portfolio looking good on paper. This article covers the three main routes a sponsor uses to get there: a sale, an IPO, and the dual-track process that keeps both options alive at once.

Route one: sale to a strategic buyer

Selling to a strategic acquirer, meaning an operating company in the same or an adjacent industry rather than another financial buyer, is often the cleanest exit route when a strong strategic buyer exists. Strategics can sometimes pay more than a financial buyer for the same asset, because they can capture synergies (cost savings, revenue cross-sell, combined market position) that a sponsor buying the same business purely as a standalone investment cannot. A strategic sale also typically closes faster and with less ongoing complexity than a public offering, since there's no new set of public shareholders to manage afterward and no lockup period before the sponsor can fully realize its proceeds.

The tradeoff is that a strategic sale depends entirely on there being a credible, motivated buyer in the market for this specific asset at this specific time, which isn't always true. A niche business with only a small number of plausible strategic acquirers gives the sponsor much less negotiating leverage than one with a broad, competitive field of potential buyers, which is exactly why the auction process covered in the LBO process from the bank's side matters so much: running a genuinely competitive process, even with a small buyer pool, is what actually produces price tension rather than a single negotiated conversation with one interested party.

Route two: sponsor-to-sponsor sale (a secondary buyout)

Sometimes the buyer on the other side of a sponsor's exit is another private equity fund, a transaction usually called a secondary buyout (and if it happens a second time to the same company, a tertiary buyout, though that's rarer and mostly a term you should recognize rather than expect to use). This has become a normal, common exit route rather than a sign of anything unusual: the exiting sponsor has run its playbook, the business has grown and matured, and a new sponsor sees a different, often lower-risk value creation thesis for the next stage of the company's life, sometimes buy-and-build consolidation, sometimes international expansion, sometimes simply continued steady growth under fresh capital and a longer runway.

Secondary buyouts also tend to move faster than a strategic sale or an IPO, since the buyer is a professional, repeat acquirer who already understands sponsor-style transactions, diligence norms, and financing structures, without needing to be educated on how a leveraged buyout works the way a first-time strategic buyer sometimes does. The buying sponsor in this scenario is doing exactly the same underwriting exercise, working backward from its own return target, described in the LBO returns article above, treating the business as a fresh platform for its own fund's thesis rather than simply continuing where the seller left off.

Route three: the IPO

Taking a portfolio company public is the most complex and most visible exit route, and it looks meaningfully different from the other two. Instead of one buyer or a small set of bidders, the company sells shares to the broad public market, typically retaining a lead investment bank (or a syndicate of banks) to manage the process, price the offering, and market the deal to institutional investors. Unlike a sale, an IPO usually doesn't let the sponsor exit its position all at once: shares sold at IPO are often only a portion of the sponsor's total stake, and the sponsor's remaining shares are typically subject to a lockup period, a set span of time after the offering during which the sponsor cannot sell additional shares, meant to prevent the market from being flooded with stock right after the offering and undermining the new public shareholders' confidence.

That means an IPO exit is really the start of a longer realization process rather than a single clean transaction: the sponsor sells down its remaining stake gradually over subsequent months and years, subject to market conditions and its own view of the stock's value, which introduces real uncertainty about the ultimate total proceeds compared to a sale, where the price is locked in at signing. The upside is that an IPO can, in the right market conditions, unlock a higher valuation than a private sale would, particularly for a business with a strong growth story that public market investors are willing to pay up for.

The dual-track process: keeping both doors open

Because a sale and an IPO require different preparation and have different risk profiles, sponsors frequently run what's called a dual-track process: preparing both a sale process and an IPO registration in parallel, without committing to either one until relatively late, then choosing whichever route offers the better outcome once real signals come in from both. This isn't indecision, it's a deliberate negotiating strategy. A sponsor running a credible dual-track process gives potential strategic and sponsor buyers a real reason to bid aggressively, since those buyers know that if their offer isn't compelling enough, the company has a genuine, prepared alternative in going public instead. Conversely, having real acquisition interest in hand strengthens the sponsor's position with underwriters and public investors if it does choose the IPO route, since it demonstrates the business has a credible floor value independent of how public markets happen to be feeling on a given week.

Running a dual-track is genuinely expensive and demanding on management's time, since it means preparing two full sets of materials and diligence simultaneously rather than committing resources to just one path, which is part of why it's reserved for larger, more valuable exits where the extra leverage it creates is worth the cost and effort.

A fourth option: not really exiting at all

There's a newer route worth knowing that doesn't fit neatly into the sell-or-go-public framing above: a continuation vehicle, where a sponsor that still believes in a portfolio company's growth prospects sets up a new fund vehicle, sells the asset into it, and gives existing fund investors the choice to cash out or roll their stake into the new structure instead. This is useful specifically when a sponsor's fund is reaching the end of its contractual life and needs to return capital to LPs, but the sponsor itself isn't ready to give up the business through a traditional sale or IPO, whether because it believes real value creation is still ahead or because market conditions for a full sale or public offering aren't attractive at that moment. It has grown from a rare workaround into a standard part of how sophisticated sponsors manage fund-life pressure without being forced into a suboptimal sale, and the full mechanics are covered in continuation vehicles and secondaries, the basics.

Timing an exit is as much art as arithmetic

Deciding when to exit, and through which route, depends on more than just whether a good offer shows up. A fund's own life-cycle pressures, covered in how private equity firms make money, can push toward an earlier exit even for a business that's still growing well, if the fund needs to return capital to LPs ahead of raising its next vehicle. Broader market receptiveness to IPOs in a given period, and the depth of the strategic and sponsor buyer pool for a given kind of business, both shift independent of anything the portfolio company itself is doing, which is why the same asset can look like an obvious sale candidate at one point and a strong IPO candidate at another, without the underlying business having changed at all.

How this shows up in interviews

A common prompt is simply "what are a sponsor's exit options, and how would you decide between them for a given company," which rewards a candidate who can name concrete tradeoffs (speed and certainty versus potential upside, buyer-pool depth, fund life-cycle pressure) rather than one who just lists the three routes. A sharper follow-up often asks why a sponsor would bother running a dual-track process instead of just picking the more likely route from the start, which is where explaining the negotiating-leverage logic, not just the mechanical definition, separates a well-prepared answer from a memorized one.

Practice question

A sponsor is deciding how to exit a portfolio company it's owned for five years. Walk me through the options and how you'd think about which one makes sense.

The sponsor generally has three routes. It can sell to a strategic buyer, which is often the fastest path to full, certain proceeds and can command a premium if the buyer can capture real synergies, but it depends on a credible, motivated buyer actually existing for this specific asset. It can sell to another sponsor in a secondary buyout, which also closes quickly with locked-in proceeds and works well when the business has matured past the exiting sponsor's original thesis but still has a credible growth story for a new owner with fresh capital. Or it can pursue an IPO, which can potentially unlock the highest valuation in strong market conditions but realizes proceeds slowly, since the sponsor typically can't sell its full stake at once and is subject to a lockup period afterward, plus ongoing market risk on the remaining shares. The right choice depends on how deep the buyer pool actually is for this specific business, how much the fund's own timeline pressures a faster exit versus allowing patience for a better IPO window, and how the business's growth story would be received by public market investors specifically versus a strategic or financial buyer. For a company with real optionality on all three fronts, many sponsors would run a dual-track process, preparing both a sale and an IPO in parallel, because having a credible alternative in hand tends to improve the terms available on whichever path is ultimately chosen.

What the interviewer is listening for: whether you can name real tradeoffs between the three routes rather than just listing them, and whether you understand why a dual-track process is a deliberate leverage strategy rather than simple indecision.